iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Mirador Capital Partners LP

Mirador Capital Partners LP trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,511 shares of the financial services provider’s stock after selling 175 shares during the period. Mirador Capital Partners LP owned 0.06% of iShares Biotechnology ETF worth $4,297,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the business. Thrive Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the third quarter valued at $445,000. Park Avenue Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $218,000. SG Americas Securities LLC grew its stake in iShares Biotechnology ETF by 16.4% during the 3rd quarter. SG Americas Securities LLC now owns 15,764 shares of the financial services provider’s stock worth $2,295,000 after buying an additional 2,223 shares during the last quarter. Appleton Partners Inc. MA increased its position in iShares Biotechnology ETF by 2.8% during the third quarter. Appleton Partners Inc. MA now owns 75,699 shares of the financial services provider’s stock worth $11,022,000 after buying an additional 2,032 shares during the period. Finally, First Financial Bank Trust Division purchased a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $204,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB traded up $1.29 during mid-day trading on Friday, reaching $143.90. 650,133 shares of the company’s stock were exchanged, compared to its average volume of 1,493,461. The business’s fifty day simple moving average is $145.48 and its 200-day simple moving average is $139.10. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.